A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS - Full Text View

A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	Gilead Sciences Anderson Clinical Research
Information provided by:	NIH AIDS Clinical Trials Information Service
ClinicalTrials.gov Identifier:	NCT00002384

Purpose

Incomplete Closed Protocol

Condition	Intervention
Cytomegalovirus Retinitis HIV Infections	Drug: Cidofovir

MedlinePlus related topics:

AIDS Cytomegalovirus Infections

ChemIDplus related topics:

Cidofovir

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS

Eligibility

Ages Eligible for Study:	13 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Information not available

Contacts and Locations

No Contacts or Locations Provided

More Information

Publications:

Stagg RJ, Gathe J, Lieberman RM, Nuessle SJ, Davis JL, Ruane P, Bellman PC, Horgan M, Jaffe HS. The Vistide (cidofovir injection) treatment IND for relapsing CMV retinitis (CMV-R). Conf Retroviruses Opportunistic Infect. 1997 Jan 22-26;4th:120 (abstract no 306)

Study ID Numbers:	276A, GS-95-120, 96ACR-GIL1
First Received:	November 2, 1999
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00002384
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Cidofovir

Sexually Transmitted Diseases, Viral

Eye Diseases

Eye Infections

Acquired Immunodeficiency Syndrome

Cytomegalovirus Retinitis

Retinitis

Cytomegalovirus

Immunologic Deficiency Syndromes

Herpesviridae Infections

Cytomegalovirus retinitis

Virus Diseases

HIV Infections

Sexually Transmitted Diseases

Cytomegalovirus Infections

DNA Virus Infections

Cytomegalic inclusion disease

Retroviridae Infections

Retinal Diseases

Additional relevant MeSH terms:

Anti-Infective Agents

RNA Virus Infections

Anti-HIV Agents

Slow Virus Diseases

Immune System Diseases

Eye Infections, Viral

Antineoplastic Agents

Physiological Effects of Drugs

Infection

Antiviral Agents

Pharmacologic Actions

Anti-Retroviral Agents

Radiation-Sensitizing Agents

Therapeutic Uses

Lentivirus Infections

ClinicalTrials.gov processed this record on September 05, 2008